查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997404

外科影像市場：按組件、技術、模式、便攜性和安裝、影像解析度和格式、臨床應用以及最終用戶分類－2026-2032年全球市場預測

Surgical Imaging Market by Component, Technology, Modality, Mobility & Installation, Imaging Resolution & Format, Clinical Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科影像市場價值將達到 42 億美元，到 2026 年將成長至 49.1 億美元，到 2032 年將達到 132.4 億美元，年複合成長率為 17.82%。

主要市場統計數據
基準年 2025 42億美元
預計年份：2026年 49.1億美元
預測年份 2032 132.4億美元
複合年成長率 (%) 17.82%

臨床重點和技術進步的融合正在將外科成像轉變為一種策略要素，從而實現卓越的技術和營運韌性。

手術影像正在重塑臨床醫生術中決策的方式，它融合了先進的視覺化技術、手術效率和以病人為中心的護理理念。在當今的外科手術環境中，人們越來越依賴高解析度影像來降低手術不確定性，實現更精準的切除、標靶介入並改善治療效果。隨著數位架構和微型化成像技術的進步，手術團隊正在採用整合式視覺化平台，這些平台結合了即時成像和導航、擴增實境（AR）疊加以及簡化的資料管理。

外科影像領域的主要結構性變化是由模態整合、軟體定義能力和價值驅動的籌資策略所驅動的。

過去幾年，外科影像領域經歷了翻天覆地的變化，這不僅體現在設備的逐步升級上，也體現在醫療服務提供和組織方式的系統性變革。其中一項根本性變革是從單一模態工具向多重模式生態系統的轉變，該系統融合了2D透視、斷層合成、CT3D重建和基於磁振造影的術中導航。這種整合提高了空間感知能力，並有助於臨床環境中複雜的決策。

關稅壓力的變化如何影響整個外科影像供應鏈的籌資策略、製造地和供應商選擇？

美國關稅情勢為採購、供應鏈規劃和供應商選擇帶來了新的考量因素，影響整個外科影像生態系統的儀器定價和籌資策略。關稅正在影響區域製造地地點的決策，一些供應商正在重新審視生產基地和供應商契約，以降低成本風險。為此，許多機構正在探索雙重採購策略、近岸外包方案以及包含價格穩定條款和庫存緩衝的長期供應商契約，以確保臨床服務的連續性。

透過協調影像技術、臨床應用和終端用戶環境的實用分割智慧，加速採用和臨床整合。

了解市場區隔趨勢對於使產品開發和市場進入策略與實際臨床需求保持一致至關重要。在將技術分為2D和3D成像時，2D成像包括立體定位成像和斷層合成等技術，這些技術仍然廣泛應用於高頻手術，因為在這些手術中，快速可視化和最小的面積佔用空間至關重要。相較之下，3D成像又細分為基於CT和基於MR的3D系統，它們著重於容積重建和軟組織對比度，用於複雜的手術規劃和術中導航。

本文探討了全球外科影像市場中決定商業性機會的採用路徑、監管反應以及區域趨勢和基礎設施差異。

區域趨勢對外科影像生態系中的技術採納、監管路徑和經營模式有顯著影響。在美洲，醫療系統對能夠提升手術效率並支援一次性支付模式的整合解決方案表現出濃厚的興趣，而北美醫療機構則往往優先考慮互通性、臨床證據和供應商的快速支援。在美洲部分地區，監管的明確性和完善的報銷機制正在加速新型術中影像應用的早期臨床部署，但由於需要獲得眾多相關人員的核准，採購週期可能會延長。

競爭格局分析揭示了平台模組化、軟體差異化和卓越服務如何推動供應商定位和夥伴關係。

外科影像中心的競爭格局由成熟的醫療設備製造商、專業軟體供應商和專注於特定臨床應用的新興技術公司共同構成。成熟的系統供應商持續投資於模組化平台，使醫療機構能夠在多個手術室擴展功能，同時利用現有服務網路確保運轉率和可預測的生命週期成本。同時，專業軟體公司憑藉先進的影像處理、導航演算法和分析功能脫穎而出，從影像資料集中挖掘更多臨床價值。

為協調採購、互通性、商業化和臨床醫生採納，創造由影像主導的永續價值，提出切實可行的策略建議。

產業領導企業應採取謹慎的態度，平衡短期營運重點與基於影像的臨床流程的長期策略投資。首先，應透過定義與影像投資相關的可衡量績效指標（例如降低再次手術率和提高術中決策的信心），使採購慣例與臨床結果目標保持一致。將採購決策與明確的臨床和財務指標掛鉤，有助於證明資本分配的合理性，並促進外科、放射科和財務等相關人員之間達成跨職能共識。

結合對臨床醫生的訪談、對臨床文獻的回顧和交叉檢驗的多方面研究途徑，將得出基於證據的策略見解。

本執行摘要的研究結合了多種定性和定量方法，以確保獲得全面而深入的見解。主要研究包括對來自不同類型和地區的醫院的臨床負責人、生物醫學工程師、採購主管和產品經理進行結構化訪談。這些訪談聚焦於術中影像實施過程中的臨床工作流程、採購標準和優先事項，從而提供了關於營運限制和決策因素的第一手觀點。

證據與策略的整合表明，協作實施影像驅動的工作流程可以持續改善病患預後和營運績效。

手術影像技術正從單純的輔助技術發展成為現代外科醫療服務的核心要素，對臨床結果、工作流程設計和供應商生態系統都產生深遠的影響。多模態影像、先進軟體和整合工作流程的融合，為減少手術差異、提高手術精準度以及實現數據驅動的改進循環創造了機會。同時，務實的籌資策略和靈活的商業性安排對於應對因關稅趨勢而更加複雜的採購和供應鏈挑戰至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科影像市場：依組件分類

  • 配件和耗材
    • 造影劑/染料（ICG）
    • 窗簾罩
  • 硬體
    • 電纜和連接設備
    • 相機鏡頭鏡
    • 檢測器和感測器
    • 顯示錄影機
    • 影像系統
    • 光源
  • 服務
    • 安裝與檢驗
    • 維護/修理
    • 託管服務
    • 培訓和教育
  • 軟體
    • 3D重建
    • 人工智慧應用
    • 劑量管理
    • 影像處理
    • 工作流程和PACS整合

第9章 外科影像市場：依技術分類

  • 2D成像
    • 立體定位成像
    • 斷層合成
  • 3D成像
    • 基於CT的3D
    • 基於磁振造影的3D

第10章 外科影像市場：依影像方式分類

  • 內視鏡成像
  • 磁振造影
  • 光學和分子成像
    • 近紅外線(NIR) / ICG螢光
    • 光學同調斷層掃描
  • 手術顯微鏡
  • 超音波
  • X光和透視
    • 固定式C臂/血管造影術
      • 吸頂式系統
      • 混合手術室系統
    • 術中CT/O臂
    • 移動式C臂
      • 全尺寸C型臂
      • 迷你C型臂

第11章 依移動性和安裝方式分類的外科影像市場

  • 固定的
    • 吸頂式
    • 落地式
  • 活動
    • 購物車類型
  • 可移動龍門架/滑動磁鐵

第12章 按影像解析度和格式分類的外科影像市場

  • 4K
  • 8K
  • 顏色
  • 可見光/近紅外線雙通道
  • HD 1080p
  • 黑白

第13章：依臨床應用分類的外科影像市場

  • 循環系統
    • 血管內
    • 結構性心臟疾病
  • 耳鼻喉科/頭頸外科
    • 鼻竇
    • 顱底
  • 一般外科
    • 大腸和直腸
    • 肝膽胰
  • 神經外科
    • 功能性/DBS
    • 腫瘤切除
  • 整形外科/創傷
    • 骨折固定
    • 脊椎手術
  • 泌尿系統和婦科
    • 子宮切除術
    • 攝護腺

第14章 外科影像市場：依最終使用者分類

  • 門診手術中心
  • 醫院
    • 大學醫院
    • 當地醫院
  • 專科診所及內部檢查室

第15章 外科影像市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 外科影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 外科影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國外科影像市場

第19章：中國外科影像市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • CONMED Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Leica Microsystems GmbH
  • Medtronic plc
  • Mindray Medical International Limited
  • Olympus Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: MRR-501246437219

The Surgical Imaging Market was valued at USD 4.20 billion in 2025 and is projected to grow to USD 4.91 billion in 2026, with a CAGR of 17.82%, reaching USD 13.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.20 billion
Estimated Year [2026] USD 4.91 billion
Forecast Year [2032] USD 13.24 billion
CAGR (%) 17.82%

How converging clinical priorities and technological advances are transforming surgical imaging into a strategic enabler of procedural excellence and operational resilience

Surgical imaging is at the confluence of advanced visualization, procedural efficiency, and patient-centered care, reshaping how clinicians approach intraoperative decision-making. Modern operating environments increasingly rely on high-fidelity imaging to reduce uncertainty during procedures, enabling more precise resections, targeted interventions, and improved outcomes. As digital architectures and miniaturized imaging technologies advance, surgical teams are adopting integrated visualization platforms that combine real-time imaging with navigation, augmented reality overlays, and streamlined data management.

Clinicians and hospital leaders now seek solutions that deliver both clinical clarity and operational value. Consequently, vendors prioritize interoperable architectures and user-centered interfaces that minimize workflow friction in high-acuity settings. The resulting shift is not merely technological; it is organizational. Cross-disciplinary teams, including surgical specialties, radiology, biomedical engineering, and IT, must align around shared performance metrics and governance for imaging-driven procedures. This transformation favors systems that balance image quality, ease of use, and seamless integration with electronic health records and perioperative information systems.

Looking ahead, the emphasis on reproducible outcomes and evidence-based procedure standardization will drive deeper collaboration between manufacturers and health systems. Investment decisions will hinge on the ability of imaging solutions to demonstrably reduce variability in procedural performance while supporting adoption through training, service, and analytics capabilities. In short, surgical imaging is evolving from an ancillary tool to a strategic enabler of procedural excellence and operational resilience.

Major structural changes in surgical imaging driven by modality convergence, software-defined capabilities, and value-oriented procurement strategies

Over the past several years, the surgical imaging landscape has experienced transformative shifts that extend beyond incremental device upgrades to systemic changes in how care is delivered and organized. One fundamental shift is the migration from single-modality tools toward multi-modal ecosystems that combine 2D fluoroscopy, tomosynthesis, CT-derived three-dimensional reconstructions, and MR-based intraoperative guidance. This amalgamation enhances spatial understanding and supports complex decision-making at the point of care.

Parallel to modality convergence is the rise of software-defined imaging. Artificial intelligence and advanced image-processing algorithms now play a central role in enhancing contrast, reducing noise, and automating routine measurements. Consequently, imaging vendors compete not only on hardware fidelity but on software capabilities that improve throughput and diagnostic confidence. Additionally, seamless connectivity and standardized data exchange protocols have catalyzed integration between imaging suites and the broader hospital infrastructure, enabling synchronized intraoperative workflows and retrospective outcome analytics.

Economic and regulatory forces have also reshaped procurement behaviors. Health systems emphasize total cost of ownership, uptime guarantees, and service models that prioritize rapid deployment and predictable maintenance. Simultaneously, clinical stakeholders demand evidence of clinical utility and value-measured through reductions in complication rates, shorter procedure times, or improved functional outcomes. Taken together, these shifts compel providers and suppliers to reorient strategies around collaborative, data-rich partnerships that accelerate adoption and scale the clinical benefits of advanced surgical imaging.

How evolving tariff pressures are reshaping procurement strategies, manufacturing footprints, and vendor selection across surgical imaging supply chains

The tariff landscape in the United States has introduced additional considerations for procurement, supply-chain planning, and vendor selection, affecting device pricing and sourcing strategies across the surgical imaging ecosystem. Tariffs influence decisions around regional manufacturing footprints, with some suppliers reassessing production locations and supplier contracts to mitigate cost exposure. In response, several organizations are exploring dual-sourcing strategies, nearshoring options, and longer-term supplier contracts that include price stabilization clauses and inventory buffering to preserve continuity of clinical services.

Operational teams and purchasing departments increasingly incorporate tariff scenarios into procurement timelines, evaluating the trade-offs between acquiring immediately available inventory versus waiting for products that can be sourced under more favorable customs conditions. As a result, procurement windows have lengthened for certain classes of imaging equipment, and capital planning cycles now more frequently include contingency allowances for import duty variability. These dynamics also incentivize vendors to offer flexible commercial terms that transfer some tariff-related risk away from the provider, such as price protection guarantees or deferred delivery agreements.

From a strategic perspective, the tariff environment accelerates vendor consolidation and local partnership models. Suppliers with established domestic manufacturing or robust localized service networks gain distinct competitive advantages because they can minimize exposure to cross-border tariff volatility while offering faster deployment and lower lifecycle logistics costs. In the near term, stakeholders should anticipate ongoing adjustments to contractual frameworks, logistics strategies, and vendor due diligence practices as organizations seek to balance cost, access, and operational certainty in a tariff-influenced environment.

Actionable segmentation intelligence that aligns imaging technologies, clinical applications, and end-user environments to accelerate adoption and clinical integration

Understanding segmentation dynamics is critical to aligning product development and go-to-market strategies with real-world clinical needs. When technologies are parsed into two-dimensional imaging and three-dimensional imaging, the two-dimensional category includes stereotactic imaging and tomosynthesis modalities that continue to serve high-volume procedures where rapid visualization and minimal footprint are paramount. In contrast, three-dimensional imaging subdivides into CT-based 3D systems and MR-based 3D systems that emphasize volumetric reconstruction and soft-tissue contrast for complex surgical planning and intraoperative guidance.

Applications shape clinical value propositions across cardiovascular, gastrointestinal, neurological, orthopedic, and urological procedures. Cardiovascular interventions prioritize high temporal resolution and precise vessel visualization to support catheter-based therapies, while gastrointestinal and urological procedures often call for compact, flexible imaging that fits within endoscopy suites. Neurological use cases demand exceptional spatial accuracy and brain-tissue contrast for resection guidance and functional preservation. Orthopedic implementations focus on bone detail and intraoperative alignment to optimize implant positioning and minimize revision rates. Tailoring product features to these differentiated clinical requirements increases adoption likelihood and reinforces clinical partnership.

End-user segmentation further refines deployment strategies, distinguishing ambulatory surgical centers, diagnostic centers, and hospitals as distinct adoption environments. Ambulatory surgical centers encompass both freestanding centers and hospital-associated centers that emphasize throughput and narrow procedural scopes. Diagnostic centers include cancer centers and imaging centers where preoperative planning, lesion localization, and biopsy guidance are primary use cases. Hospitals split into private and public institutions that balance broader procedural portfolios, complex case mixes, and centralized procurement processes. Recognizing these distinctions enables providers and vendors to match solution form factors, service models, and pricing structures to the operational realities and decision-making pathways of each customer type.

Regional dynamics and infrastructure variance that determine adoption pathways, regulatory readiness, and commercial opportunity across global surgical imaging markets

Regional dynamics exert a strong influence on technology adoption, regulatory pathways, and commercial models within the surgical imaging ecosystem. In the Americas, health systems exhibit a strong appetite for integrated solutions that demonstrate procedural efficiency and support bundled payment models, with North American centers often prioritizing interoperability, clinical evidence, and rapid vendor support networks. Regulatory clarity and established reimbursement pathways in portions of the region facilitate earlier clinical introduction for novel intraoperative imaging applications, although procurement cycles can remain elongated due to multi-stakeholder approvals.

In Europe, the Middle East & Africa, regulatory diversity and heterogeneity in healthcare infrastructure lead to differentiated adoption patterns. Western European centers frequently adopt advanced imaging modalities quickly when supported by clear health-technology assessments and clinical guideline endorsements, while other parts of the region require solutions that emphasize cost-effectiveness and adaptable service models. In the Middle East and parts of Africa, investment in tertiary centers and referral hospitals drives interest in high-end imaging platforms for specialized procedures, but broader system-level capacity constraints can slow diffusion.

Across the Asia-Pacific region, rapid infrastructure investment, expanding private hospital networks, and increasing emphasis on surgical subspecialization create fertile conditions for imaging innovation. Countries with strong medical-device ecosystems show accelerated uptake of hybrid operating rooms and image-guided surgery suites, whereas emerging markets prioritize compact and cost-effective solutions that fit constrained capital budgets. Moreover, the Asia-Pacific region is becoming an important manufacturing and R&D base for vendors looking to optimize cost structures and shorten supply chains, which in turn impacts global deployment timelines and commercial partnerships.

Competitive landscape analysis revealing how platform modularity, software differentiation, and service excellence drive vendor positioning and partnerships

Competitive dynamics in surgical imaging center on a mix of established device manufacturers, specialized software vendors, and emerging technology entrants that focus on niche clinical applications. Established system providers continue to invest in modular platforms that allow providers to scale functionality across multiple operating rooms while leveraging existing service networks to ensure uptime and predictable lifecycle costs. At the same time, specialist software firms are differentiating through advanced image processing, navigation algorithms, and analytics that extract incremental clinical value from imaging datasets.

Strategic alliances, targeted acquisitions, and co-development partnerships characterize current activity as vendors seek to pair hardware excellence with software intelligence and clinical workflow expertise. These collaborations often prioritize integration with electronic medical records, cloud-based analytics, and surgical planning tools to deliver seamless end-to-end workflows. Additionally, suppliers are experimenting with subscription and outcome-based contracting models that align vendor compensation with clinical performance, offering providers alternative ways to access advanced imaging capabilities without large upfront capital expenditure.

Service excellence remains a competitive differentiator. Vendors that offer comprehensive training, rapid field service, and proactive parts management secure stronger adoption and higher lifetime value. Meanwhile, newer entrants that bring disruptive capabilities-such as AI-driven tissue characterization or compact intraoperative MR solutions-must prioritize rigorous clinical validation and post-deployment support to gain the trust of surgical teams and procurement committees.

Practical strategic recommendations designed to align procurement, interoperability, commercialization, and clinician adoption for sustained imaging-driven value

Industry leaders should adopt a deliberate approach that balances near-term operational priorities with longer-term strategic investments in imaging-enabled care pathways. First, align procurement practices with clinical outcome objectives by defining measurable performance indicators tied to imaging investments, such as reductions in reoperation rates or improvements in intraoperative decision confidence. Linking purchasing decisions to clear clinical and financial metrics helps justify capital allocation and supports cross-functional buy-in across surgical, radiology, and finance stakeholders.

Second, prioritize interoperability and open standards when evaluating new systems. Solutions that support standardized data exchange and integrate with navigation, electronic records, and analytics platforms reduce implementation friction and future-proof investments against evolving digital architectures. Third, consider flexible commercial models that mitigate tariff and supply-chain risks, including options for localized maintenance agreements, extended warranties, and phased deployments that spread capital exposure while delivering incremental clinical capability.

Fourth, invest in clinician adoption through structured training programs, simulation-based onboarding, and multidisciplinary governance that embeds imaging into clinical protocols. Effective change management accelerates utilization and maximizes return on technology investments. Finally, cultivate innovation partnerships with academic centers and technology firms to pilot advanced applications-such as AI-assisted tissue delineation or augmented-reality overlays-under controlled study conditions that generate evidence for scaled adoption.

A multi-method research approach that integrates clinician interviews, clinical literature review, and cross-validation to produce evidence-grounded strategic insights

The research underpinning this executive summary combined multiple qualitative and quantitative approaches to ensure robust, multi-perspective insights. Primary research included structured interviews with clinical leaders, biomedical engineers, procurement executives, and product managers across diverse hospital types and geographic regions. These conversations focused on clinical workflows, procurement criteria, and priorities for intraoperative imaging adoption, providing firsthand perspectives on operational constraints and decision drivers.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product brochures, and public company disclosures to validate clinical claims, technological capabilities, and commercial strategies. The analytical framework integrated technology assessment with application mapping and end-user segmentation to generate actionable insights. Across stages, findings were triangulated through cross-validation workshops with subject-matter experts to reconcile conflicting inputs and test hypothesis sensitivity.

Limitations include variation in regional regulatory environments and heterogeneity in reporting standards across institutions, which the methodology accounted for through stratified sampling and sensitivity analyses. Where appropriate, assumptions were explicitly documented and expert consensus was used to interpret ambiguous or proprietary data. This mixed-methods approach yields a balanced, evidence-grounded perspective designed to inform operational decisions and strategic planning for stakeholders in surgical imaging.

Synthesis of evidence and strategy showing how collaborative adoption of imaging-enabled workflows can sustainably improve patient outcomes and operational performance

Surgical imaging is transitioning from a supporting technology to a central component of modern surgical care delivery, with implications for clinical outcomes, workflow design, and supplier ecosystems. The convergence of multi-modal imaging, advanced software, and connected workflows creates opportunities to reduce procedural variability, enhance surgical precision, and enable data-driven improvement cycles. At the same time, procurement and supply-chain complexities-heightened by tariff dynamics-require pragmatic sourcing strategies and flexible commercial arrangements.

Organizations that proactively align clinical goals with procurement and vendor partnerships stand to realize the greatest benefit. Emphasizing interoperability, rigorous clinical validation, and comprehensive service models will accelerate adoption and embed imaging within standardized care pathways. Meanwhile, vendors that marry hardware performance with software intelligence and dependable service will maintain competitive advantage.

Ultimately, the path forward rests on collaboration: between surgeons, radiologists, biomedical teams, and industry partners to operationalize imaging capabilities in ways that measurably improve patient care and institutional performance. By prioritizing evidence, interoperability, and clinician-centered design, stakeholders can navigate current headwinds and harness surgical imaging as a durable source of clinical differentiation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Imaging Market, by Component

  • 8.1. Accessories & Consumables
    • 8.1.1. Contrast Agents & Dyes (ICG)
    • 8.1.2. Drapes & Covers
  • 8.2. Hardware
    • 8.2.1. Cables & Connectivity
    • 8.2.2. Camera Heads & Scopes
    • 8.2.3. Detectors & Sensors
    • 8.2.4. Displays & Recorders
    • 8.2.5. Imaging Systems
    • 8.2.6. Light Sources
  • 8.3. Services
    • 8.3.1. Installation & Validation
    • 8.3.2. Maintenance & Repair
    • 8.3.3. Managed Services
    • 8.3.4. Training & Education
  • 8.4. Software
    • 8.4.1. 3D Reconstruction
    • 8.4.2. AI Applications
    • 8.4.3. Dose Management
    • 8.4.4. Image Processing
    • 8.4.5. Workflow & PACS Integration

9. Surgical Imaging Market, by Technology

  • 9.1. 2D Imaging
    • 9.1.1. Stereotactic Imaging
    • 9.1.2. Tomosynthesis
  • 9.2. 3D Imaging
    • 9.2.1. Ct-Based 3D
    • 9.2.2. Mr-Based 3D

10. Surgical Imaging Market, by Modality

  • 10.1. Endoscopic Imaging
  • 10.2. Magnetic Resonance
  • 10.3. Optical & Molecular Imaging
    • 10.3.1. NIR/ICG Fluorescence
    • 10.3.2. Optical Coherence Tomography
  • 10.4. Surgical Microscopy
  • 10.5. Ultrasound
  • 10.6. X-Ray & Fluoroscopy
    • 10.6.1. Fixed C-Arm/Angiography
      • 10.6.1.1. Ceiling-Mounted System
      • 10.6.1.2. Hybrid OR System
    • 10.6.2. Intraoperative CT/O-Arm
    • 10.6.3. Mobile C-Arm
      • 10.6.3.1. Full-Size C-Arm
      • 10.6.3.2. Mini C-Arm

11. Surgical Imaging Market, by Mobility & Installation

  • 11.1. Fixed
    • 11.1.1. Ceiling-Mounted
    • 11.1.2. Floor-Mounted
  • 11.2. Mobile
    • 11.2.1. Cart-Based
  • 11.3. Movable Gantry/Sliding Magnet

12. Surgical Imaging Market, by Imaging Resolution & Format

  • 12.1. 4K
  • 12.2. 8K
  • 12.3. Color
  • 12.4. Dual-Channel Visible/NIR
  • 12.5. HD 1080p
  • 12.6. Monochrome

13. Surgical Imaging Market, by Clinical Application

  • 13.1. Cardiovascular
    • 13.1.1. Endovascular
    • 13.1.2. Structural Heart
  • 13.2. ENT/Head & Neck
    • 13.2.1. Sinus
    • 13.2.2. Skull Base
  • 13.3. General Surgery
    • 13.3.1. Colorectal
    • 13.3.2. Hepatobiliary
  • 13.4. Neurosurgery
    • 13.4.1. Functional/DBS
    • 13.4.2. Tumor Resection
  • 13.5. Orthopedic & Trauma
    • 13.5.1. Fracture Fixation
    • 13.5.2. Spine Surgery
  • 13.6. Urology & Gynecology
    • 13.6.1. Hysterectomy
    • 13.6.2. Prostate

14. Surgical Imaging Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
    • 14.2.1. Academic Medical Centers
    • 14.2.2. Community Hospitals
  • 14.3. Specialty Clinics & Office-Based Labs

15. Surgical Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Surgical Imaging Market

19. China Surgical Imaging Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Canon Medical Systems Corporation
  • 20.6. Carl Zeiss Meditec AG
  • 20.7. CONMED Corporation
  • 20.8. FUJIFILM Holdings Corporation
  • 20.9. GE HealthCare Technologies Inc.
  • 20.10. Hologic, Inc.
  • 20.11. KARL STORZ SE & Co. KG
  • 20.12. Koninklijke Philips N.V.
  • 20.13. Leica Microsystems GmbH
  • 20.14. Medtronic plc
  • 20.15. Mindray Medical International Limited
  • 20.16. Olympus Corporation
  • 20.17. Shimadzu Corporation
  • 20.18. Siemens Healthineers AG
  • 20.19. Smith & Nephew plc
  • 20.20. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 4K, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 4K, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 4K, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 8K, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 8K, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 8K, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DUAL-CHANNEL VISIBLE/NIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DUAL-CHANNEL VISIBLE/NIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DUAL-CHANNEL VISIBLE/NIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HD 1080P, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HD 1080P, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HD 1080P, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MONOCHROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MONOCHROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MONOCHROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STRUCTURAL HEART, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STRUCTURAL HEART, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STRUCTURAL HEART, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SINUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SINUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SINUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SKULL BASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SKULL BASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SKULL BASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HEPATOBILIARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HEPATOBILIARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HEPATOBILIARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FUNCTIONAL/DBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FUNCTIONAL/DBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FUNCTIONAL/DBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYSTERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYSTERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL IMAGING MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL IMAGING MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL IMAGING MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPECIALTY CLINICS & OFFICE-BASED LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPECIALTY CLINICS & OFFICE-BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SPECIALTY CLINICS & OFFICE-BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 260. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 261. AMERICAS SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 262. AMERICAS SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 263. AMERICAS SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 264. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 265. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 266. AMERICAS SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. AMERICAS SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. AMERICAS SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 270. AMERICAS SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 271. AMERICAS SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 272. AMERICAS SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 273. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2032 (USD MILLION)
  • TABLE 274. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2032 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2018-2032 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. AMERICAS SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 280. AMERICAS SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, 2018-2032 (USD MILLION)
  • TABLE 281. AMERICAS SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 282. AMERICAS SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 283. AMERICAS SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 284. AMERICAS SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. AMERICAS SURGICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. AMERICAS SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 290. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 292. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 296. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 298. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 300. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2032 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2018-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY ENT/HEAD & NECK, 2018-2032 (USD MILLION)
  • TABLE 308. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 310. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY ORTHOPEDIC & TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY UROLOGY & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 314. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 316. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 318. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 322. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 324. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 326. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY FIXED C-AR